BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31156795)

  • 21. KRAS polymorphisms are associated with survival of CRC in Chinese population.
    Dai Q; Wei HL; Huang J; Zhou TJ; Chai L; Yang ZH
    Tumour Biol; 2016 Apr; 37(4):4727-34. PubMed ID: 26515332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TYMS 2R3R polymorphism and DPYD [IVS]14+1G>A gene mutation in Mexican colorectal cancer patients.
    Gallegos-Arreola MP; Zúñiga-González GM; Sánchez-López JY; Cruz AYN; Peralta-Leal V; Figuera LE; Puebla-Pérez AM; Ronquillo-Carreón CA; Puebla-Mora AG
    Acta Biochim Pol; 2018; 65(2):227-234. PubMed ID: 29906295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3'-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patients.
    Sebio A; Paré L; Páez D; Salazar J; González A; Sala N; del Río E; Martín-Richard M; Tobeña M; Barnadas A; Baiget M
    Pharmacogenet Genomics; 2013 Mar; 23(3):142-7. PubMed ID: 23324806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
    Liang Y; Sun R; Li L; Yuan F; Liang W; Wang L; Nie X; Chen P; Zhang L; Gao L
    Medicine (Baltimore); 2015 Aug; 94(31):e1289. PubMed ID: 26252302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Let-7 miRNA-binding site polymorphism in the KRAS 3'UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.
    Kjersem JB; Ikdahl T; Guren T; Skovlund E; Sorbye H; Hamfjord J; Pfeiffer P; Glimelius B; Kersten C; Solvang H; Tveit KM; Kure EH
    BMC Cancer; 2012 Nov; 12():534. PubMed ID: 23167843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.
    Smits KM; Paranjape T; Nallur S; Wouters KA; Weijenberg MP; Schouten LJ; van den Brandt PA; Bosman FT; Weidhaas JB; van Engeland M
    Clin Cancer Res; 2011 Dec; 17(24):7723-31. PubMed ID: 21994416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.
    Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.
    Uvirova M; Simova J; Kubova B; Dvorackova N; Tomaskova H; Sedivcova M; Dite P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):466-71. PubMed ID: 26077004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.
    Wang WY; Chien YC; Wong YK; Lin YL; Lin JC
    Head Neck; 2012 May; 34(5):663-6. PubMed ID: 21688344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective role of +294 T/C (rs2016520) polymorphism of PPARD in Mexican patients with colorectal cancer.
    Rosales-Reynoso MA; Wence-Chavez LI; Arredondo-Valdez AR; Dumois-Petersen S; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
    Genet Mol Res; 2017 Jan; 16(1):. PubMed ID: 28128413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A let-7 microRNA-binding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy.
    Zhang W; Winder T; Ning Y; Pohl A; Yang D; Kahn M; Lurje G; LaBonte MJ; Wilson PM; Gordon MA; Hu-Lieskovan S; Mauro DJ; Langer C; Rowinsky EK; Lenz HJ
    Ann Oncol; 2011 Jan; 22(1):104-109. PubMed ID: 20603437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single nucleotide polymorphism in the 3'-untranslated region of the KRAS gene disrupts the interaction with let-7a and enhances the metastatic potential of osteosarcoma cells.
    Zhang S; Hou C; Li G; Zhong Y; Zhang J; Guo X; Li B; Bi Z; Shao M
    Int J Mol Med; 2016 Sep; 38(3):919-26. PubMed ID: 27430246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between KRAS gene polymorphisms and genetic susceptibility to breast cancer in a Chinese population.
    Jin M; Lu F; Li X; Zhou W; Li S; Jiang Y; Wu H; Wang J
    J Clin Lab Anal; 2023 Jan; 37(1):e24806. PubMed ID: 36510353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-Converting Enzyme Gene Deletion Polymorphism is Associated with Lymph Node Metastasis in Colorectal Cancer Patients in a Chinese Population.
    Zheng X; Liu G; Cui G; Cheng M; Zhang N; Hu S
    Med Sci Monit; 2017 Oct; 23():4926-4931. PubMed ID: 29032382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-binding site polymorphisms and risk of colorectal cancer: A systematic review and meta-analysis.
    Gholami M; Larijani B; Sharifi F; Hasani-Ranjbar S; Taslimi R; Bastami M; Atlasi R; Amoli MM
    Cancer Med; 2019 Dec; 8(17):7477-7499. PubMed ID: 31637880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A let-7 microRNA binding site polymorphism in the KRAS 3'UTR is associated with increased risk and reduced survival for gallbladder cancer in North Indian population.
    Kazmi HR; Chandra A; Kumar S; Satyam LK; Gupta A; Nigam J; Srivastava M; Mittal B
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2577-2583. PubMed ID: 27620744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians.
    Mustapha MA; Shahpudin SN; Aziz AA; Ankathil R
    World J Gastroenterol; 2012 Jun; 18(21):2668-73. PubMed ID: 22690076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single Nucleotide Polymorphisms in MicroRNA-Binding Site of Epidermal Growth Factor Receptor Signaling Pathway and Susceptibility to Esophageal Squamous Cell Carcinoma.
    Qu Y; Zhang Y; Wang K; Song C; Wang P; Ye H; Zhang J; Dai L
    Dig Dis; 2020; 38(1):1-8. PubMed ID: 31269493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of the rs8720 and rs12587
    Gallegos-Arreola MP; Garibaldi-Ríos AF; Cruz-Sánchez JI; Figuera LE; Ronquillo-Carreón CA; Rosales-Reynoso MA; Gómez-Meda BC; Carrillo-Dávila IA; Puebla-Pérez AM; Montoya-Fuentes H; Peralta-Leal V; Zúñiga-González GM
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of polymorphisms in microRNA-binding sites and colorectal cancer in an Iranian population.
    Azimzadeh P; Romani S; Mohebbi SR; Mahmoudi T; Vahedi M; Fatemi SR; Zali N; Zali MR
    Cancer Genet; 2012 Oct; 205(10):501-7. PubMed ID: 22939228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.